Clinical Trial

Methotrexate in Erosive Inflammatory Hand Osteoarthritis

Study acronym: MERINO
Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A placebo-controlled randomized controlled trial exploring the effect of methotrexate on pain, function and structural outcomes in erosive inflammatory hand osteoarthritis.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-10-01; most recent amendment 2025-12-15.
Status change: Recruiting → Active, Not Recruiting 2025-12-15
Status change: Not Yet Recruiting → Recruiting 2021-08-31
Trial Details
NCT Number NCT04579848
Lead Sponsor Diakonhjemmet Hospital
Collaborators: Oslo University Hospital
Conditions Hand Osteoarthritis, Erosive Osteoarthritis
Enrollment 163 participants
Start Date 2021-08-12
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-19